Taken together, these data demonstrated that Rspo2 exacerbated articular cartilage damage and synovitis to promote the progression of RA, whereas Rspo2-NAb or rmDKK1 could effectively mitigate the development of RA. Here, RSPO2 is linked to rheumatoid arthritis.